Health Care & Life Sciences » Pharmaceuticals | Aurobindo Pharma Ltd.

Aurobindo Pharma Ltd. | Ownership

Companies that own Aurobindo Pharma Ltd.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
HDFC Asset Management Co. Ltd. (Invt Mgmt)
35,120,236
5.99%
106,099
1.77%
07/31/2018
Aditya Birla Sun Life AMC Ltd.
16,244,940
2.77%
-74,547
1.31%
07/31/2018
Reliance Nippon Life Asset Management Ltd. (Invt Mgmt)
12,892,979
2.2%
-798,170
0.95%
08/31/2018
The Vanguard Group, Inc.
9,258,446
1.58%
154,360
0%
07/31/2018
BlackRock Fund Advisors
7,089,122
1.21%
-6,748
0%
09/06/2018
SBI Funds Management Pvt Ltd.
4,529,855
0.77%
200,888
0.26%
06/30/2018
GIC Pte Ltd. (Investment Management)
4,137,850
0.71%
4,137,850
0.06%
03/31/2017
Dimensional Fund Advisors LP
3,562,232
0.61%
13,577
0.01%
04/30/2018
APG Asset Management NV
3,454,659
0.59%
-2,015,300
0.02%
03/31/2018
ICICI Prudential Asset Management Co. Ltd.
3,014,316
0.51%
8,832
0.17%
08/31/2018

About Aurobindo Pharma

View Profile
Address
Water Mark Building
Hyderabad TS 500084
India
Employees -
Website http://www.aurobindo.com
Updated 09/14/2018
Aurobindo Pharma Ltd. engages in the manufacture of generic pharmaceuticals and active pharmaceutical ingredients. It operates through the following geographical segments: India, USA, Europe, and Rest of the World. It portfolio includes antibiotics, anti-retrovirals, cardiovascular, central nervous system, gastroenterological, anti-allergies, and anti-diabetics.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.